

United for Children‟s Inter Development Action Uganda (UNCIDA) is a not-for-profit organisation founded in 2008. They work to defend child rights, save lives, fight inequality to end poverty and injustices with particular focus on programs that contribute to the strengthening of local, protective environment, and improved social transformation and well-being in the lives of children, youth and their families through innovative partnerships and by strengthening the voice of and for the poor, marginalised and vulnerable communities. They implement high-impact and quality thematic priority areas of child protection and gender-based violence; child rights governance; health and nutrition; water, sanitation and hygiene; conflict resolution and peacebuilding; education; renewable energy; climate change adaptation and mitigation in development and emergency context. NCIDA is committed to supporting children, adolescents, youth, women in families and communities affected by disasters/Floods, armed conflicts; public health emergencies and we provide a variety of assistance through our child protection and gender; Education, Health (MNCH, ASRHR, HIV, TB, Malaria, Food, Hepatitis B) and Nutrition; Water, Sanitation and Hygiene; Conflicts and Peacebuilding; climate and energy and Innovations in western region of Uganda. They include hepatitis in their health programmes, and they do awareness creation, advocacy, capacity building of stakeholders and patients with treatment knowledge and information.
Hepatitis and PWID/harm reduction
11:35 – 11:40
Chair: WHO – Intro and set the scene.
11:40 – 11:55
Co-chair: EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe.
11:55 – 12:00
ID 29: Ema Pos (not yet registered)
Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation.
12:05 – 12:10
ID 152: Brian Conway (Registered in person)
Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.
12:10 – 12:15
ID 212: Jasmine West (not yet registered)
Title: From lived experience to lived expertise: a syndemic approach.
12:15 – 12:20
ID: 299 Mercy Nyakowa (Registered in person)
Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya
12:20 – 12:25
ID: 133 Nalinikanta Rajkumar (Registered in person)
Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?
12:25 – 12:30
Q&A and closing remarks
tHIS
IS
BEN’S
BIG
TEST
effective case finding strategies
Supported by Vir Biotechnology, Inc
During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.
Session Agenda
14:40 – 14:45
Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)
14:45 – 15:05
Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology
15:05 – 15:10
Final remarks and close